Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Dual TxA2/LT receptor antagonist selected for development by Yamanouchi

April 17, 1997

Biogen reveals new cell adhesion inhibitor

April 16, 1997

Schering-Plough's Nasonex approved in U.K. and France

April 15, 1997

Nasacort now available for the treatment of allergic rhinitis

April 15, 1997

ABT-761 reduces bronchoconstriction and pulmonary inflammation in animals

April 14, 1997

First CFC-free inhaler launched in U.S.

April 14, 1997

Treatment for rhinitis undergoes further development in Australia

April 11, 1997

Norastemizole demonstrates high efficacy, safety and rapid onset of action in humans

April 10, 1997

New LTD4 antagonist from Fujisawa

April 10, 1997

Dual H1/PAF antagonists disclosed by British Biotech

April 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
ATNM-400 radioconjugate shows efficacy in resistant breast cancer
BioWorld Science
Although hormone receptor-positive (HR+) breast cancer accounts for over 70% of cases, 20%-30% of patients still experience relapse despite endocrine therapies...